
USFDA APPLICATION NUMBER - 50629 / DOSAGE - INJECTABLE;INJECTION - 2MG/ML
| Active Ingredient/Active Moiety | ||
| Ingredient Name | Basis of Strength | Strength |
|---|---|---|
| DOXORUBICIN HYDROCHLORIDE(UNII: 82F2G7BL4E) (DOXORUBICIN - UNII:80168379AG) | DOXORUBICIN HYDROCHLORIDE | 2mg in 1 | 2mg in 1 | 2mg in 1 | 2mg in 1 | 2mg in 1 |
Inactive Ingredients
| Ingredient Name | Actavis Pharma, Inc. | Alvogen Inc. | Amneal-Agila, LLC | Gland Pharma Limited | Hikma Pharmaceuticals USA Inc. | Mylan Institutional LLC | Northstar RxLLC | Pfizer Laboratories Div Pfizer Inc | Teva Parenteral Medicines, Inc. |
|---|---|---|---|---|---|---|---|---|---|
| HYDROCHLORIC ACID(QTT17582CB) | |||||||||
| SODIUM CHLORIDE(451W47IQ8X) | |||||||||
| SODIUM HYDROXIDE(55X04QC32I) | |||||||||
| WATER(059QF0KO0R) |